Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound

Atrophic vaginitis is the pathologic thinning of the vaginal mucosa caused by the lack of adequate estrogen in menopause, perimenopause, or by contraceptive medications. Historically, treatment has been the replacement of estrogen, either systemically or locally, applied to the vaginal mucosa. Intra...

Full description

Saved in:
Bibliographic Details
Main Author THOMPSON RONALD J
Format Patent
LanguageEnglish
Published 16.11.2006
Subjects
BANDAGES, DRESSINGS OR ABSORBENT PADS
DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS
FILTERS IMPLANTABLE INTO BLOOD VESSELS
FIRST-AID KITS
FOMENTATION
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROSTHESES
TREATMENT OR PROTECTION OF EYES OR EARS
Online AccessGet full text

Cover

More Information
Summary:Atrophic vaginitis is the pathologic thinning of the vaginal mucosa caused by the lack of adequate estrogen in menopause, perimenopause, or by contraceptive medications. Historically, treatment has been the replacement of estrogen, either systemically or locally, applied to the vaginal mucosa. Intravaginally applied tissue moisturizers have proven as effective as estrogen in therapy for atrophic vaginitis. We hereby describe a treatment of atrophic vaginitis that is non-hormonal and does not require intravaginal application, but rather relies upon the production of a natural vaginal serum transudate. This natural vaginal serum transudate lubrication is reflexly invoked by the daily external stimulation of the clitoral nociceptors, to treat atrophic vaginitis.
Bibliography:Application Number: US20060483324